Bench to Beside Technology: Nanobios Lab Industry Academia Translational Bridge

Abstract

In the biomedical field, translational research has become a prior need for bridging the gap between industry and academia for the budding entrepreneurs and scientists. Translational research has various interdisciplinary scopes, but it is complex, unlike other non-medical product developments, as it deals with lives (both animals and humans). For developing bench to beside technologies, various factors such as repeatability, reliability, scalability, compatibility, compliance, adverse effects, regulatory approvals, relevance commercial potential and many more human factors need to be explored. Apart from these, other aspects like drug design/or development, bioengineering approaches, chemical synthesis methodologies, choice of diagnostics and therapeutics kit or tool, supply industries, nano(bio)technology, tissue printing, diagnostics and many others need to be studied. To the best of our knowledge, an academia-industry partnership and multidisciplinary collaborations may reduce various related hurdles. Among 200 research groups/laboratories, NanoBios has emerged as a pathbreaker in this field based on its diverse portfolio, world class resources, co-existence of various collaborative facilities, pool of scholars, industry partners, funding, and all other decorations required for exemplary translational research works. Commercial exploitation incentivizes innovations, and the lab has created an impact in the Indian startup space within a decade by transferring many technologies to the industries, ultimately incubating an entrepreneurial environment within an academic institute where various stakeholders benefit from each other as well as meet societal needs by generating indigenous translational products.